Breaking News

Huntingdon Life Sciences Acquires Harlan Labs

May 2, 2014

Will operate Research Models and Contract Research Divisions

Huntingdon Life Sciences, a global provider of non-clinical contract research services to the pharma, crop protection and chemical industries, has acquired Harlan Laboratories. The new company will have two divisions dedicated to Research Models and Services and Contract Research Services.
 
Harlan provides non-clinical contract research, research models, animal diets, and services to the pharma/biopharma industry, medical device, crop protection and chemical industries, as well as universities, government, and other research organizations.
 
Brian Cass, chief executive officer of Huntingdon Life Sciences, said, "We are excited by the acquisition of Harlan, a highly respected leader in their market sectors. This acquisition is precisely in line with our strategy to broaden our support for the pharmaceutical, crop protection and chemical industries, as well as universities, government, and other research organizations. Our two companies have a long heritage and together we will maintain and build on our reputation for high quality science and innovation."
 
Harlan chief executive officer Hans Thunem said, "Merging these two leading companies, with their complementary product and service offerings, positions the combined organization as a global leader in supporting the growing market for outsourced research and development. Brian and his newly expanded team bring enormous depth and experience to the increasingly complex challenges facing non-clinical and pre-clinical researchers."
 
blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Heavy Metals in Drug Products

    Heavy Metals in Drug Products

    Nikki Schopp, Team Leader in charge of ICP-MS, ICP-OES and AA testing, SGS||January 29, 2015
    The potential presence of trace amounts of heavy metals in drug products is a real cause for concern with regulators.

  • Microbiological Testing & Contamination Control

    Microbiological Testing & Contamination Control

    Daniel L. Prince, Ph. D., Christopher J. Waskewich, M.S., Kristah J. Kohan, B.S. and Danina G. Rinaldi, B.S. , Gibraltar Laboratories, Inc.||March 7, 2014
    An opinion on the microbial limit test with reference to harmonization.